Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges

Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment over the past decade. However, although the immune landscape suggests a strong rationale for the use of these agents in patients with head and neck squamous cell carcinoma, the available clinical evidence indicates that most pat...

Full description

Bibliographic Details
Main Authors: Jack M. Qian, Jonathan D. Schoenfeld
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
anti-PD-1
immunotherapy
radiation therapy
head and neck cancer
anti-PD-L1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.608772/full

Similar Items

Similar Items